A Randomized, Double-Blind, Placebo-controlled, Parallel Design Clinical Study to Evaluate the Effect of Different Doses of UC-II ® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects

Condition:   Joint Pain Interventions:   Other: Collagen type II (40 mg/day);   Other: Collagen type II (80mg/day);   Other: Collagen type II (120 mg/day);   Other: Glucosamine Hydrochloride with Chondroitin Sulphate (2700 mg);   Other: Placebo Sponsor:   Vedic Lifesciences Pvt. Ltd. Not yet recruiting

Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials